update
Janssen accuses Celltrion's media supplier HyClone of patent infringement
Janssen says culture media HyClone Laboratories makes for Celltrion infringe on a US patent covering broths used in the manufacture of Remicade (infliximab).
Archives for June 23, 2016
UK Biopharma looks to remain strong as Brexit leads to uncharted waters
The UK biosimilars industry has urged the Government to push for a single marketing authorisation in its upcoming negotiations with the EU, following today’s shock Brexit result.
MAb characterisation course could reskill small molecule API workers, NIBRT
Interested in moving from small to large molecule manufacturing? An upcoming course will address mAb characterisation challenges and offer hands-on experience for small molecule manufacturers , says NIBRT, Ireland’s biomanufacturing training centre.